Altrinsic Global Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$35.1M |
| 2 |
Thomson Reuters
TRI
|
+$23.4M |
| 3 |
Oracle
ORCL
|
+$15.1M |
| 4 |
Comcast
CMCSA
|
+$12.6M |
| 5 |
Molson Coors Class B
TAP
|
+$4.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XL
XL Group Ltd.
XL
|
+$63.3M |
| 2 |
ICICI Bank
IBN
|
+$60.5M |
| 3 |
Cisco
CSCO
|
+$14.4M |
| 4 |
Vodafone
VOD
|
+$10.9M |
| 5 |
Chubb
CB
|
+$8.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.89% |
| 2 | Communication Services | 15.11% |
| 3 | Healthcare | 12.26% |
| 4 | Technology | 10.72% |
| 5 | Industrials | 7.87% |
Similar funds
Altrinsic Global Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Altrinsic Global Advisors held 86 positions worth $2.48B, down 5% from $2.61B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Altrinsic Global Advisors withdrew a net $108M in Q1 2018, closing 4 positions and reducing 34 holdings. Its most notable exit was Kindred Healthcare, an estimated $2.78M position sold in full.
By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 33% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Altrinsic Global Advisors opened a new position in Regenxbio worth $1.79M.
- Altrinsic Global Advisors's largest Q1 2018 buy was Regenxbio: 60,000 shares worth $1.79M.
- Altrinsic Global Advisors added most to Check Point Software Technologies in Q1 2018, an estimated $35.1M increase.
- Altrinsic Global Advisors's biggest Q1 2018 reduction was XL Group Ltd., cutting an estimated $63.3M.
- Altrinsic Global Advisors fully exited Kindred Healthcare in Q1 2018, selling an estimated $2.78M.
- Altrinsic Global Advisors's ten largest holdings make up 52% of its $2.48B portfolio in Q1 2018.
- Altrinsic Global Advisors opened 4 new positions and closed 4 in Q1 2018.
- Altrinsic Global Advisors's portfolio value fell 5% quarter-over-quarter to $2.48B.
Based on Altrinsic Global Advisors's 13F filing for Q1 2018, filed 14 May 2018.